Anna Kobsar

1.2k total citations
44 papers, 967 citations indexed

About

Anna Kobsar is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Anna Kobsar has authored 44 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 19 papers in Cardiology and Cardiovascular Medicine and 6 papers in Physiology. Recurrent topics in Anna Kobsar's work include Platelet Disorders and Treatments (24 papers), Antiplatelet Therapy and Cardiovascular Diseases (15 papers) and Nitric Oxide and Endothelin Effects (5 papers). Anna Kobsar is often cited by papers focused on Platelet Disorders and Treatments (24 papers), Antiplatelet Therapy and Cardiovascular Diseases (15 papers) and Nitric Oxide and Endothelin Effects (5 papers). Anna Kobsar collaborates with scholars based in Germany, Russia and Ireland. Anna Kobsar's co-authors include Ulrich Walter, Martin Eigenthaler, Stepan Gambaryan, Johann Bauersachs, Andreas Schäfer, Suzanne M. Lohmann, Daniela Fraccarollo, Georg Ertl, Natalia Rukoyatkina and Jörg Geiger and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Anna Kobsar

43 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Kobsar Germany 16 280 279 243 159 143 44 967
Yi Ma China 13 176 0.6× 252 0.9× 326 1.3× 217 1.4× 121 0.8× 24 942
Ahmed Aburima United Kingdom 17 208 0.7× 246 0.9× 265 1.1× 173 1.1× 114 0.8× 31 901
Beverley Koller United States 8 147 0.5× 348 1.2× 322 1.3× 446 2.8× 81 0.6× 9 1.3k
Jan Willem N. Akkerman Netherlands 18 520 1.9× 280 1.0× 254 1.0× 95 0.6× 110 0.8× 29 1.2k
Naziba Islam United States 13 156 0.6× 181 0.6× 168 0.7× 147 0.9× 116 0.8× 16 890
Roger van Kruchten Netherlands 14 581 2.1× 325 1.2× 387 1.6× 296 1.9× 167 1.2× 18 1.6k
Pieter J. Oort United States 12 777 2.8× 156 0.6× 468 1.9× 131 0.8× 374 2.6× 14 1.5k
Thati Madhusudhan Germany 18 375 1.3× 188 0.7× 497 2.0× 226 1.4× 101 0.7× 33 1.4k
Brian Estevez United States 10 305 1.1× 165 0.6× 212 0.9× 155 1.0× 54 0.4× 13 782
Hirotaka Isobe Japan 15 342 1.2× 169 0.6× 395 1.6× 208 1.3× 226 1.6× 29 1.2k

Countries citing papers authored by Anna Kobsar

Since Specialization
Citations

This map shows the geographic impact of Anna Kobsar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kobsar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kobsar more than expected).

Fields of papers citing papers by Anna Kobsar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Kobsar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kobsar. The network helps show where Anna Kobsar may publish in the future.

Co-authorship network of co-authors of Anna Kobsar

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Kobsar. A scholar is included among the top collaborators of Anna Kobsar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Kobsar. Anna Kobsar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobsar, Anna, et al.. (2024). Effect of toxins from different periodontitis‐associated bacteria on human platelet function. Molecular Oral Microbiology. 39(6). 468–476.
2.
Weber, Katja, et al.. (2021). Influence of long-term proteasome inhibition on platelet responsiveness mediated by bortezomib. Vascular Pharmacology. 138. 106830–106830. 5 indexed citations
3.
Üçeyler, Nurcan, et al.. (2021). Profile of the single‐use, multiple‐pass protein A adsorber column in immunoadsorption. Vox Sanguinis. 117(3). 393–398. 2 indexed citations
4.
Weber, Katja, et al.. (2019). The Role of Human Platelet Preparation for Toll-Like Receptors 2 and 4 Related Platelet Responsiveness. SHILAP Revista de lepidopterología. 3(2). e94–e102. 15 indexed citations
5.
Weber, Katja, et al.. (2018). The role of agonist-induced activation and inhibition for the regulation of purinergic receptor expression in human platelets. Thrombosis Research. 168. 40–46. 13 indexed citations
6.
Weber, Katja, et al.. (2016). Evaluation of dose-dependent effects of the proteasome inhibitor bortezomib in human platelets. European Journal of Pharmacology. 791. 99–104. 7 indexed citations
7.
Weber, Katja, et al.. (2016). Expression and function of purinergic receptors in platelets from apheresis-derived platelet concentrates.. PubMed. 14(6). 545–551. 8 indexed citations
10.
Gambaryan, Stepan, Sabrina Hebling, Christian P. Speer, et al.. (2011). Neisseria meningitidis induces platelet inhibition and increases vascular endothelial permeability via nitric oxide regulated pathways. Thrombosis and Haemostasis. 106(12). 1127–1138. 10 indexed citations
11.
Wiegering, Verena, Beate Winkler, Matthias Wölfl, et al.. (2011). Allogeneic Hematopoietic Stem Cell Transplantation in Glanzmann Thrombasthenia Complicated by Platelet Alloimmunization. Klinische Pädiatrie. 223(3). 173–175. 8 indexed citations
12.
13.
Ehrenschwender, Martin, et al.. (2011). Evaluation of the new INNOVANCE® PFA P2Y cartridge in patients with impaired primary haemostasis. Platelets. 23(8). 571–578. 7 indexed citations
14.
Gambaryan, Stepan, Anna Kobsar, Natalia Rukoyatkina, et al.. (2010). Thrombin and Collagen Induce a Feedback Inhibitory Signaling Pathway in Platelets Involving Dissociation of the Catalytic Subunit of Protein Kinase A from an NFκB-IκB Complex. Journal of Biological Chemistry. 285(24). 18352–18363. 123 indexed citations
15.
16.
Schäfer, Andreas, Daniela Fraccarollo, Ulrike Flierl, et al.. (2007). Improvement of vascular function by acute and chronic treatment with the PDE‐5 inhibitor sildenafil in experimental diabetes mellitus. British Journal of Pharmacology. 153(5). 886–893. 59 indexed citations
17.
Lohmann, Tobias, Anna Kobsar, A. Siegemund, et al.. (2006). Enhanced platelet activation by prolactin in patients with ischemic stroke. Thrombosis and Haemostasis. 96(7). 38–44. 47 indexed citations
18.
Wallaschofski, Henri, Anna Kobsar, Olga Sokolova, Martin Eigenthaler, & Tobias Lohmann. (2004). Co-activation of Platelets by Prolactin or Leptin - Pathophysiological Findings and Clinical Implications. Hormone and Metabolic Research. 36(1). 1–6. 24 indexed citations
19.
Eigenthaler, Martin, Stefan Engelhardt, Anna Kobsar, et al.. (2003). Disruption of cardiac Ena-VASP protein localization in intercalated disks causes dilated cardiomyopathy. American Journal of Physiology-Heart and Circulatory Physiology. 285(6). H2471–H2481. 35 indexed citations
20.
Eigenthaler, Martin, et al.. (2003). Activated platelets induce migration, proliferation and gene expression in human vascular endothelial cells. Journal of Thrombosis and Haemostasis. 1. P0164–P0164. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026